Company: CORT
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001628280-25-019942
Chunk: 34

Company: CORCEPT THERAPEUTICS INC
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 34
---
good reason” (as each term is defined in the agreements) prior to or more than 18 months following a change in control, the executive will be eligible to receive 12 months of his or her then-current base salary, payable in substantially equal installments in accordance with the Company’s customary payroll procedures, and continued health insurance coverage for up to 12 months following the date of termination. In addition, the agreements provide that in the event the executive’s employment is terminated by us without “cause” or by the executive for “good reason” within 18 months following a change in control, the executive will be eligible to receive an amount equal to 12 months of his or her then-current base salary payable in a lump sum, continued health insurance coverage for up to 12 months following the date of termination, and full vesting of all outstanding equity awards. The receipt of any severance will be subject to the executive signing and not revoking a separation agreement and release of claims in a form reasonably acceptable to us within 60 days following executive’s termination of employment. No severance will be paid or provided until the separation agreement and release of claims becomes effective.

The following table reflects compensation payable to each of our named executive officers upon a change in control or various employment termination events. The amounts shown below assume that (i) the named executive officer experienced a qualifying termination effective as of December 31, 2024 or (ii) a change in control of our Company occurred and the named executive officer experienced a qualifying termination on December 31, 2024.

<div align='center'>23</div>

| Name                     |     | Benefit                                                   |     | Termination For Any Reason Outside of a 
 Change in Control                       |           |     | Termination For Any Reason Within 18 Months Following a Change in Control |            |     |    |
|:-------------------------|:----|:----------------------------------------------------------|:----|:----------------------------------------|----------:|:----|:--------------------------------------------------------------------------|-----------:|:----|---:|
| Joseph K. Belanoff, M.D. |     | Base Salary                                               |     | $                                       | 1,144,000 |     | $                                                                         |  1,144,000 |     |    |
|                          |     | Accelerated Vesting of Stock Options and Restricted Stock |     |                                         |         — |     |                                                                           | 23,216,738 |     | -1 |
|                          |     | Health Insurance Benefit                                  |     |